Effect of soluble ICAM-1 on a sjögren's syndrome-like phenotype in NOD mice is disease stage dependent

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Roescher, Nienke ^a,b   Vosters, Jelle L ^a,b   Yin, Hongen ^b   Illei, Gabor G ^b   Tak, Paul P ^a   Chiorini, John A ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SJOEGREN SYNDROME; STABLE TRANSFECTION; TRANSGENE; VIRAL GENE THERAPY; VIRUS RECOMBINANT; ANIMAL; IMMUNOLOGY; METABOLISM; NONOBESE DIABETIC MOUSE; SALIVA; SECRETION;

ADENO-ASSOCIATED VIRUS; MUS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; INTERCELLULAR ADHESION MOLECULE-1; MICE; MICE, INBRED NOD; SALIVA; SJOGREN'S SYNDROME;

EID: 79955940817     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019962     Document Type: Article

References (25)

1. Deeths MJ, Mescher MF, (1999) ICAM-1 and B7-1 provide similar but distinct costimulation for CD8+ T cells, while CD4+ T cells are poorly costimulated by ICAM-1. Eur J Immunol 29: 45-53.
2. Poudrier J, Owens T, (1994) CD54/intercellular adhesion molecule 1 and major histocompatibility complex II signaling induces B cells to express interleukin 2 receptors and complements help provided through CD40 ligation. J Exp Med 179: 1417-1427.
3. Aziz KE, McCluskey PJ, Montanaro A, Wakefield D, (1992) Vascular endothelium and lymphocyte adhesion molecules in minor salivary glands of patients with Sjogren's syndrome. J Clin Lab Immunol 37: 39-49.
4. Kapsogeorgou EK, Dimitriou ID, Abu-Helu RF, Moutsopoulos HM, Manoussakis MN, (2001) Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjogren's syndrome: high expression of intercellular adhesion molecule-1 (ICAM.1) in biopsy specimens and cultured cells. Clin Exp Immunol 124: 126-133.
5. Chen WS, Lin KC, Chen CH, Liao HT, Wang HP, et al. (2009) Autoantibody and biopsy grading are associated with expression of ICAM-1, MMP-3, and TRAIL in salivary gland mononuclear cells of Chinese patients with Sjogren's syndrome. J Rheumatol 36: 989-996.
6. Turkcapar N, Sak SD, Saatci M, Duman M, Olmez U, (2005) Vasculitis and expression of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin in salivary glands of patients with Sjogren's syndrome. J Rheumatol 32: 1063-1070.
7. Kok MR, Baum BJ, Tak PP, Pillemer SR, (2003) Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjogren's syndrome. Ann Rheum Dis 62: 1038-1046.
8. Thanou-Stavraki A, James JA, (2008) Primary Sjogren's syndrome: current and prospective therapies. Semin Arthritis Rheum 37: 273-292.
9. Martin S, Heidenthal E, Schulte B, Rothe H, Kolb H, (1998) Soluble forms of intercellular adhesion molecule-1 inhibit insulitis and onset of autoimmune diabetes. Diabetologia 41: 1298-1303.
10. Bertry-Coussot L, Lucas B, Danel C, Halbwachs-Mecarelli L, Bach JF, et al. (2002) Long-term reversal of established autoimmunity upon transient blockade of the LFA-1/intercellular adhesion molecule-1 pathway. J Immunol 168: 3641-3648.
11. Cha S, Nagashima H, Brown VB, Peck AB, Humphreys-Beher MG, (2002) Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjogren's syndrome) on a healthy murine background. Arthritis Rheum 46: 1390-1398.
12. Faveeuw C, Gagnerault MC, Lepault F, (1994) Expression of homing and adhesion molecules in infiltrated islets of Langerhans and salivary glands of nonobese diabetic mice. J Immunol 152: 5969-5978.
13. Moutsopoulos HM, (1994) Sjogren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 72: 162-165.
14. Tsunawaki S, Nakamura S, Ohyama Y, Sasaki M, Ikebe-Hiroki A, et al. (2002) Possible function of salivary gland epithelial cells as nonprofessional antigen-presenting cells in the development of Sjogren's syndrome. J Rheumatol 29: 1884-1896.
15. Yamano S, Huang LY, Ding C, Chiorini JA, Goldsmith CM, et al. (2002) Recombinant adeno-associated virus serotype 2 vectors mediate stable interleukin 10 secretion from salivary glands into the bloodstream. Hum Gene Ther 13: 287-298.
16. Kok MR, Yamano S, Lodde BM, Wang J, Couwenhoven RI, et al. (2003) Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjogren's syndrome. Hum Gene Ther 14: 1605-1618.
17. Anderson ME, Siahaan TJ, (2003) Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors. Peptides 24: 487-501.
18. Mikulowska-Mennis A, Xu B, Berberian JM, Michie SA, (2001) Lymphocyte migration to inflamed lacrimal glands is mediated by vascular cell adhesion molecule-1/alpha(4)beta(1) integrin, peripheral node addressin/l-selectin, and lymphocyte function-associated antigen-1 adhesion pathways. Am J Pathol 159: 671-681.
19. Gottenberg JE, Cagnard N, Lucchesi C, Letourneur F, Mistou S, et al. (2006) Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proc Natl Acad Sci U S A 103: 2770-2775.
20. Wu AJ, Kurrasch RH, Katz J, Fox PC, Baum BJ, et al. (1994) Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of a human salivary gland cell line. J Cell Physiol 161: 217-226.
21. Doerck S, Gobel K, Weise G, Schneider-Hohendorf T, Reinhardt M, et al. Temporal pattern of ICAM-I mediated regulatory T cell recruitment to sites of inflammation in adoptive transfer model of multiple sclerosis. PLoS One 5: e15478.
22. Voutetakis A, Kok MR, Zheng C, Bossis I, Wang J, et al. (2004) Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics. Proc Natl Acad Sci U S A 101: 3053-3058.
23. Nikolov NP, Nagaraju K, Ghimbovschi S, Alba M, Lapteva L, et al. (2009) Blocking LFA-1 with Efalizumab Promotes Inflammation, T Cell Activation and Autoimmunity in Primary Sjögren's Syndrome. Arthritis Rheum 60: 499.
24. Kaludov N, Brown KE, Walters RW, Zabner J, Chiorini JA, (2001) Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J Virol 75: 6884-6893.
25. Haringman JJ, Vinkenoog M, Gerlag DM, Smeets TJ, Zwinderman AH, et al. (2005) Reliability of computerized image analysis for the evaluation of serial synovial biopsies in randomized controlled trials in rheumatoid arthritis. Arthritis Res Ther 7: R862-867.